FR2815641B1 - METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS - Google Patents
METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONSInfo
- Publication number
- FR2815641B1 FR2815641B1 FR0013650A FR0013650A FR2815641B1 FR 2815641 B1 FR2815641 B1 FR 2815641B1 FR 0013650 A FR0013650 A FR 0013650A FR 0013650 A FR0013650 A FR 0013650A FR 2815641 B1 FR2815641 B1 FR 2815641B1
- Authority
- FR
- France
- Prior art keywords
- atheroscleric
- lesions
- prevention
- applications
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003902 lesion Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Environmental Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pathology (AREA)
- Animal Husbandry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0013650A FR2815641B1 (en) | 2000-10-24 | 2000-10-24 | METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS |
| PCT/FR2001/003303 WO2002034941A1 (en) | 2000-10-24 | 2001-10-24 | Method for screening active molecules for treating and preventing atherosclerotic lesions and its uses |
| AU2002214093A AU2002214093A1 (en) | 2000-10-24 | 2001-10-24 | Method for screening active molecules for treating and preventing atherosclerotic lesions and its uses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0013650A FR2815641B1 (en) | 2000-10-24 | 2000-10-24 | METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2815641A1 FR2815641A1 (en) | 2002-04-26 |
| FR2815641B1 true FR2815641B1 (en) | 2002-12-27 |
Family
ID=8855703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0013650A Expired - Fee Related FR2815641B1 (en) | 2000-10-24 | 2000-10-24 | METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002214093A1 (en) |
| FR (1) | FR2815641B1 (en) |
| WO (1) | WO2002034941A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5675062A (en) * | 1994-07-18 | 1997-10-07 | President And Fellows Of Harvard College | Cellular basis of transplant arteriosclerosis in mice |
| FR2792205B1 (en) * | 1999-04-19 | 2001-07-27 | Inst Nat Sante Rech Med | PHARMACEUTICAL COMPOSITION COMPRISING NKT CELLS ACTIVATED BY IMP, AND ITS USE IN THERAPY |
-
2000
- 2000-10-24 FR FR0013650A patent/FR2815641B1/en not_active Expired - Fee Related
-
2001
- 2001-10-24 AU AU2002214093A patent/AU2002214093A1/en not_active Abandoned
- 2001-10-24 WO PCT/FR2001/003303 patent/WO2002034941A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2815641A1 (en) | 2002-04-26 |
| AU2002214093A1 (en) | 2002-05-06 |
| WO2002034941A1 (en) | 2002-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60109589D1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN, CHRONIC PAIN AND / OR NEUROPATHIC PAIN AND MIGRAINE | |
| PT1083889E (en) | TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| ATE306481T1 (en) | PYRAZOLECARBOXAMIDE USED TO TREAT OBESITY AND OTHER DISEASES | |
| EP1551416A4 (en) | METHOD OF TREATING DYSERECTION AND INCREASING LIBIDO IN MAN | |
| EP1537140A4 (en) | NUCLEIC ACID AND CORRESPONDING PROTEIN 161P2F10B USEFUL IN THE TREATMENT AND DETECTION OF CANCER | |
| MA27374A1 (en) | ESTER OF 2'-C-METHYL-3'-O-L-VALINE AND RIBOFURANOSYL CYTIDINE FOR THE TREATMENT OF FLAVIVIRIDAE INFECTIONS | |
| EP1100119A4 (en) | PLASMA TREATMENT PROCESS | |
| EP1429793A4 (en) | NUCLEIC ACID AND CORRESPONDING PROTEIN DESIGNATED BY STEAP-1 USEFUL IN THE TREATMENT AND DETECTION OF CANCER | |
| FR2804603B1 (en) | CONTINUOUS PROCESS FOR FORMULATING IN THE FORM OF GRANULES ONE OR MORE PHARMACEUTICAL ACTIVE SUBSTANCES | |
| ITTO20001156A0 (en) | EQUIPMENT FOR THE DISGREGATION TREATMENT OF BIOLOGICAL SAMPLES AND DISGREGATION DEVICE FOR USE IN SAID EQUIPMENT. | |
| DE60032910D1 (en) | MEDIUM FOR THE DETECTION AND TREATMENT OF DISEASES RELATED TO FGFR3 | |
| DE69925578D1 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES RELATED TO EYE-BASED CELL-DISEASES | |
| EP1572887A4 (en) | NEURAL REGENERATION PEPTIDES AND METHODS OF USE THEREOF IN THE TREATMENT OF CEREBRAL LESIONS | |
| FR2772142B1 (en) | ANTI-REFLECTIVE TREATMENT METHOD AND MATERIAL PRESENTING ANTI-REFLECTIVE PROPERTIES | |
| FR2797875B1 (en) | SPHERICAL TELITHROMYCIN AGGLOMERATES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION IN THE PREPARATION OF PHARMACEUTICAL FORMS | |
| EP1848440A4 (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBRES IN THE TREATMENT OF MUSCULAR LESIONS | |
| PT1152756E (en) | USEFUL ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AUTISM | |
| FR2815641B1 (en) | METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS | |
| EP1412293A4 (en) | APPARATUS AND METHOD FOR TREATING WASTEWATER BY THE IMPROVED SOLID REDUCTION (ESR) TECHNIQUE | |
| EP1383922A4 (en) | NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 158P3D2 USEFUL IN THE TREATMENT AND DETECTION OF CANCER | |
| EP1840948A4 (en) | FINE TREATMENT AGENT AND FINE TREATMENT METHOD USING THE SAME | |
| ATE314064T1 (en) | L-ACETYLCARNITINE AND L-PROPIONYLCARNITINE COMPOSITION FOR THE PREVENTION AND TREATMENT OF KIDNEY DISORDERS AND KIDNEY DISEASE | |
| FR2724376B1 (en) | PROCESS OF IN SITU TREATMENT OF SEDIMENTS AND IN PARTICULAR VASES | |
| AU2002364890A8 (en) | Molecules for disease detection and treatment | |
| EP1581634A4 (en) | METHOD FOR THE TREATMENT OF PHARMACODEPENDANCE AND SCREENING OF PHARMACEUTICAL AGENTS USEFUL FOR THIS TREATMENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |